Deutsche Bank’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-15,957
Closed -$1.56M 5028
2015
Q1
$1.56M Sell
15,957
-35,683
-69% -$3.48M ﹤0.01% 2590
2014
Q4
$4.79M Buy
51,640
+20,179
+64% +$1.87M ﹤0.01% 1978
2014
Q3
$2.16M Buy
31,461
+21,947
+231% +$1.51M ﹤0.01% 2446
2014
Q2
$997K Sell
9,514
-32,561
-77% -$3.41M ﹤0.01% 2892
2014
Q1
$3.49M Buy
42,075
+6,922
+20% +$574K ﹤0.01% 2056
2013
Q4
$2.27M Sell
35,153
-7,494
-18% -$485K ﹤0.01% 2220
2013
Q3
$2.7M Buy
42,647
+19,250
+82% +$1.22M ﹤0.01% 2272
2013
Q2
$980K Buy
+23,397
New +$980K ﹤0.01% 2717